SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in LYEL — Lyell Immunopharma, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in LYEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$6,222,571 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
18 quarters on record
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Derivatives in LYEL
reported options exposure · as of Jun 30, 2026CallValue
$363,895
CallShares
25,900
PutValue
$199,510
PutShares
14,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in LYEL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $363,895 | 25,900 | Call | Other | 2026-08-14 | |
| 2026-06-30 | $199,510 | 14,200 | Put | Other | 2026-08-14 | |
| 2026-03-31 | $6,222,571 | 310,198 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $258,552 | 8,400 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $4,648,272 | 151,016 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $262,422 | 16,159 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $198,016 | 22,400 | Call | Other | 2025-08-14 | |
| 2025-03-31 | $126,399 | 234,944 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $117,852 | 184,144 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $164,650 | 119,312 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $630,150 | 282,579 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $929,999 | 479,381 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $289,404 | 196,875 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $614,037 | 193,094 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $519,015 | 219,922 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $191,943 | 55,315 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $888,608 | 121,229 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $223,487 | 44,255 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $79,714 | 10,299 | Shares | Defined | 2022-04-05 | |
| 2021-09-30 | $473,822 | 32,015 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||